Director/PDMR Shareholding

RNS Number : 6654C

Dechra Pharmaceuticals PLC

20 October 2020

 

20 October 2020

Dechra^® Pharmaceuticals PLC

(Dechra or the Company)

LEI: 213800J4UVB5OWG8VX82

Notification and public disclosure of transactions by

persons discharging managerial responsibilities (PDMRs)

Grant of SAYE options:

Dechra Pharmaceuticals PLC announces that on 19 October 2020 the following PDMRs were granted options over ordinary shares of 1p each in the Company pursuant to the Dechra Global Save As You Earn Plan 2018 (the Options).

The Options have been granted with an exercise price of £28.68.

Name	Capacity	Options Granted
Ian Page	Director	627
Paul Sandland	Director	627

The Notification of Dealing Forms set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.

Notification of Dealing Form

1.	Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")
a)	Name	Ian Page
2.	Reason for the notification
a)	Position/status	Director/PDMR
b)	Initial notification/ amendment	Initial Notification
3.	Details of the Issuer
a)	Name	Dechra Pharmaceuticals PLC
b)	LEI code	213800J4UVB5OWG8VX82
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification code	Ordinary Shares of 1 pence each ISIN: GB0009633180
b)	Nature of the transaction	Grant of 627 options under the Company's Save As You Earn Scheme
c)	Price(s) and volumes(s)	Price(s) £28.68	Volume(s) 627
d)	Aggregated information -  Aggregate volume -  Price	627 £17,982.36
e)	Date of the transaction	2020.10.19
f)	Place of the transaction	Outside a trading venue

1.	Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")
a)	Name	Paul Sandland
2.	Reason for the notification
a)	Position/status	Director/PDMR
b)	Initial notification/ amendment	Initial Notification
3.	Details of the Issuer
a)	Name	Dechra Pharmaceuticals PLC
b)	LEI code	213800J4UVB5OWG8VX82
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification code	Ordinary Shares of 1 pence each ISIN: GB0009633180
b)	Nature of the transaction	Grant of 627 options under the Company's Save As You Earn Scheme
c)	Price(s) and volumes(s)	Price(s) £28.68	Volume(s) 627
d)	Aggregated information -  Aggregate volume -  Price	627 £17,982.36
e)	Date of the transaction	2020.10.19
f)	Place of the transaction	Outside a trading venue

For further information, please contact:

Melanie Hall, Company Secretary 

Telephone number: 01606 814730

About Dechra

Dechra is a global specialist veterinary pharmaceuticals and related products business.  Our expertise is in the development, manufacture, marketing and sales of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

 

END

 

 

DSHKKKBPKBDDCKB